financetom
Business
financetom
/
Business
/
Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation
Nov 4, 2025 10:26 AM

With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a national leader in pharmaceutical compounding while pursuing its mission to elevate patient care through innovation, scale, and quality.

GILBERT, AZ / ACCESS Newswire ( ACCS ) / November 4, 2025 / Strive Pharmacy, a leader in personalized healthcare solutions, today announced a significant milestone in its ongoing expansion and mission to redefine what's possible in pharmaceutical compounding with the acquisition of a state-of-the-art manufacturing facility in Alachua, FL., and the expansion of Strive's Tampa operations. These moves reflect the company's continued dedication to growth, innovation, and its core philosophy to NEVER SETTLE.

With these and other initiatives in development, Strive will operate over 700,000 square feet of combined facilities, making it the largest and most advanced compounding pharmacy network in the nation and positioned to support various needs that meet the industry's growing demand for quality compounded medications at scale.

The newly acquired 275,000-square-foot Current Good Manufacturing Practice (CGMP) facility in Alachua has high-tech production, fulfillment, and other drug manufacturing capabilities, including biologics and API. With major pharmaceutical manufacturing companies valuing the facility at upwards of $500M, Strive intends to transform it into the leading 503B outsourcing and contract manufacturing site within the next 12-18 months. Once operational, the site will significantly expand Strive's ability to deliver high-quality therapeutics through multiple channels while maintaining the company's gold-standard commitment to quality.

Strive's new Alachua facility

"This facility represents more than just growth; it's an investment in the future of patient access and pharmaceutical excellence," said Nate Hill, CEO and co-founder of Strive Pharmacy. "The Alachua site will position Strive at the forefront of innovation, allowing us to serve providers and patients on a broader scale while maintaining the precision, quality, and care that define who we are."

At the same time, Strive has completed the expansion and transfer of its Tampa location, a move designed to raise the standard for the patient experience. The new space increases production capacity and introduces a reimagined front lobby that reflects Strive's patient-first approach, warm, transparent, and service-oriented. The Tampa site strengthens Strive's presence in the Southeast, enabling faster fulfillment, improved service levels, and expanded therapeutic reach.

Strive's new Tampa location

"Every investment we make, whether it's infrastructure, technology, or talent, is about keeping our brand promise to patients and providers," said Mike Walker, President and co-founder at Strive Pharmacy. "We're building the systems and capabilities this industry deserves, because people's health depends on it."

These initiatives underscore Strive's commitment to set the standard for quality, innovation, and patient care across the nation. The company continues to invest in breakthrough technologies, recruit top-tier talent, and strengthen its operations so that patients and providers always have access to the highest quality care and compounds.

"At Strive, we're not just expanding-we're evolving," added Walker. "We're setting a new benchmark for what it means to serve patients with excellence, transparency, and compassion."

About Strive Pharmacy:

Strive Pharmacy is on a mission to make personalized medicine mainstream. With a strong focus on quality, customization, and a commitment to putting people over profit, Strive Compounding Pharmacy is redefining what personalized healthcare can look like-one prescription at a time. Whether through brick-and-mortar partnerships or innovative telehealth collaborations, Strive Compounding Pharmacy continues to push the boundaries of what's possible in modern medicine. For more information, visit Strive Compounding Pharmacy's website at https://www.strivepharmacy.com/.

Media Contact:

Zach Shurtleff

Chief Marketing Officer

[email protected]

www.strivepharmacy.com

SOURCE: Strive Pharmacy

View the original press release on ACCESS Newswire ( ACCS )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
This sustainable jewellery brand is luring some women away from gold
This sustainable jewellery brand is luring some women away from gold
Oct 30, 2023
Aulerth's offerings range from ₹5,000 to as high as ₹2.8 lakh. Are women willing to spend this much on jewellery made from scrap? Founder and CEO Vivek Ramabhadran definitely believes so. Aulerth produces couture-inspired pieces in association with designers like JJ Valaya, Suneet Varma, among others. It has reported 33% repeat customers in the past year and expects a spike to 40% soon.
Tata Power Renewable Energy wins 200-MW project in collaboration with SJVN
Tata Power Renewable Energy wins 200-MW project in collaboration with SJVN
Nov 28, 2023
The firm and dispatchable renewable energy (FDRE) project, designed with a hybrid of solar, wind, and battery storage, is aimed at providing a stable and dispatchable energy supply during peak hours. Shares of Tata Power Company Ltd ended at ₹270.75, up by ₹12.60, or 4.88%, on the BSE.
Suzlon's S144–3 MW wind turbines get big boost from Indian government
Suzlon's S144–3 MW wind turbines get big boost from Indian government
Nov 15, 2023
Th Suzlon wind turbines received the RLMM (Revised List of Models & Manufacturers) listing from the Ministry of New and Renewable Energy, marking an important milestone for the successful commercialisation of the product. Shares of Suzlon Energy Ltd ended at ₹40.49, up by ₹1.85, or 4.79%, on the BSE.
SJVN secures 200-MW wind power project at ₹3.24 per unit
SJVN secures 200-MW wind power project at ₹3.24 per unit
Nov 16, 2023
Projected to generate 482 million units in its inaugural year post-commissioning, the cumulative energy generation over a 25-year span is anticipated to reach 12,050 million units. Shares of SJVN Ltd ended at ₹75.17, down by ₹0.50, or 0.66%, on the BSE.
Copyright 2023-2026 - www.financetom.com All Rights Reserved